SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028766
Filing Date
2018-11-09
Accepted
2018-11-09 08:37:31
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q asns-10q_20180930.htm 10-Q 2092723
2 EX-31.1 asns-ex311_12.htm EX-31.1 19154
3 EX-31.2 asns-ex312_7.htm EX-31.2 21053
4 EX-32.1 asns-ex321_13.htm EX-32.1 10605
5 EX-32.2 asns-ex322_9.htm EX-32.2 11806
  Complete submission text file 0001564590-18-028766.txt   6344016

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT asns-20180930.xml EX-101.INS 1148716
7 XBRL TAXONOMY EXTENSION SCHEMA asns-20180930.xsd EX-101.SCH 54299
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asns-20180930_cal.xml EX-101.CAL 45837
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asns-20180930_def.xml EX-101.DEF 141519
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE asns-20180930_lab.xml EX-101.LAB 360726
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asns-20180930_pre.xml EX-101.PRE 277813
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 181171487
SIC: 2836 Biological Products, (No Diagnostic Substances)